AI assistant
Sending…
Ocugen, Inc. — Director's Dealing 2019
Dec 13, 2019
32915_dirs_2019-12-13_7e495f51-02d9-4d67-9263-5cb6230ee280.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2019-09-27
Reporting Person: Musunuri Shankar (Director, Chief Executive Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1375299 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants (Right to Buy) | $7.56 | 2027-09-14 | Common Stock (7191) | Direct | |
| Warrants (Right to Buy) | $5.05 | 2026-12-08 | Common Stock (405) | Indirect | |
| Stock Option (right to buy) | $1.88 | 2025-08-26 | Common Stock (86292) | Direct |
Footnotes
F1: The Reporting Person is a member and officer of KVM Holdings, LLC and has voting and investment power power over the shares held by KVM Holdings, LLC.
F2: 100% of the Warrants became exercisable immediately.
F3: 100% of the Stock Options became exercisable immediately.
More from Ocugen, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 20
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4